# Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

Study · id `cardio:ct-nct01376557` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01376557](<https://clinicaltrials.gov/study/NCT01376557>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01376557

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 299 participants.

## Technical summary

Registry record NCT01376557. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2014-10-31.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 299 participants (enrolled count; ClinicalTrials.gov record NCT01376557, source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01376557, source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)
- Primary completion: 2012-05 (actual) (ClinicalTrials.gov record NCT01376557, source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)
- Completion: 2012-05 (actual) (ClinicalTrials.gov record NCT01376557, source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)
- Results first posted: 2014-10-31 (ClinicalTrials.gov record NCT01376557, source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01376557, source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01376557-2014-10-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): 75 mg LX4211
- Intervention (Drug): 200 mg LX4211
- Intervention (Drug): 400 mg LX4211
- Intervention (Drug): 200 mg LX4211
- Intervention (Drug): Placebo
- Lead sponsor: Lexicon Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Lexicon Pharmaceuticals (`cardio:org-lexicon-pharmaceuticals`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy (`cardio:pubmed-25216510`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4bbd1acc10d8b284ea3945d98f2981b2dbdbf5f8a2d41add27ed8abf784be8d7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
